BAK1 and Keratoconjunctivitis sicca: Rossi et al., using the definition of dry eye as the presence of superficial punctuate keratitis and decreased fluorescein break-up time, showed a higher incidence of dry eye in patients taking topical ocular medication containing BAK than controls (P < 0.01) [26].